The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United States,” announced Swedish Match, a subsidiary of Philip Morris (PM) International. “The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21-plus,” the company added. Tom Hayes, president of Swedish Match North America, added: “The FDA’s decision recognizes the role that ZYN can play in the protection of the public health by helping people switch from cigarettes and other traditional tobacco products.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PM:
- FDA authorization of ZYN pouches ‘slight positive’ for Philip Morris, says UBS
- FDA authorizes marketing of 20 Zyn nicotine pouch products
- Netflix upgraded, AMD downgraded: Wall Street’s top analyst calls
- Philip Morris initiated with an Overweight at Morgan Stanley
- FDA proposes plan to make cigarettes ‘nonaddictive’ by limiting tobacco